Reply to H. B et al

Anne-Sophie Defachelles; Emilie Bogart; Michela Casanova; Johannes H M Merks; Gianni Bisogno; Giuseppina Calareso; Soledad Gallego Melcon; Susanne Andrea Gatz; Marie-Cécile Le Deley; Kieran McHugh; Alicia Probst; Nathalie Rocourt; Rick R van Rijn; Véronique Minard-Colin; Julia C Chisholm

doi:10.1200/JCO.21.02612

Reply to H. B et al

Anne-Sophie Defachelles, Emilie Bogart, Michela Casanova, Johannes H M Merks, Gianni Bisogno, Giuseppina Calareso, Soledad Gallego Melcon, Susanne Andrea Gatz, Marie-Cécile Le Deley, Kieran McHugh, Alicia Probst, Nathalie Rocourt, Rick R van Rijn, Véronique Minard-Colin, Julia C Chisholm

Group Merks

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Originele taal-2	Engels
Pagina's (van-tot)	1030-1032
Aantal pagina's	3
Tijdschrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume	40
Nummer van het tijdschrift	9
DOI's	https://doi.org/10.1200/JCO.21.02612
Status	Gepubliceerd - feb. 2022

Toegang tot document

10.1200/JCO.21.02612

Citeer dit

Defachelles, A-S., Bogart, E., Casanova, M., Merks, J. H. M., Bisogno, G., Calareso, G., Melcon, S. G., Gatz, S. A., Le Deley, M-C., McHugh, K., Probst, A., Rocourt, N., van Rijn, R. R., Minard-Colin, V., & Chisholm, J. C. (2022). Reply to H. B et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 40(9), 1030-1032. https://doi.org/10.1200/JCO.21.02612

@article{b08d2d1c904749e089617fcadeb8c370,

title = "Reply to H. B et al",

keywords = "Child, Humans, Irinotecan, Rhabdomyosarcoma, Sarcoma, Temozolomide, Therapies, Investigational, Vincristine",

author = "Anne-Sophie Defachelles and Emilie Bogart and Michela Casanova and Merks, {Johannes H M} and Gianni Bisogno and Giuseppina Calareso and Melcon, {Soledad Gallego} and Gatz, {Susanne Andrea} and {Le Deley}, Marie-C{\'e}cile and Kieran McHugh and Alicia Probst and Nathalie Rocourt and {van Rijn}, {Rick R} and V{\'e}ronique Minard-Colin and Chisholm, {Julia C}",

year = "2022",

month = feb,

doi = "10.1200/JCO.21.02612",

language = "English",

volume = "40",

pages = "1030--1032",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "9",

}

Defachelles, A-S, Bogart, E, Casanova, M, Merks, JHM, Bisogno, G, Calareso, G, Melcon, SG, Gatz, SA, Le Deley, M-C, McHugh, K, Probst, A, Rocourt, N, van Rijn, RR, Minard-Colin, V & Chisholm, JC 2022, 'Reply to H. B et al', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 40, nr. 9, blz. 1030-1032. https://doi.org/10.1200/JCO.21.02612

TY - JOUR

T1 - Reply to H. B et al

AU - Defachelles, Anne-Sophie

AU - Bogart, Emilie

AU - Casanova, Michela

AU - Merks, Johannes H M

AU - Bisogno, Gianni

AU - Calareso, Giuseppina

AU - Melcon, Soledad Gallego

AU - Gatz, Susanne Andrea

AU - Le Deley, Marie-Cécile

AU - McHugh, Kieran

AU - Probst, Alicia

AU - Rocourt, Nathalie

AU - van Rijn, Rick R

AU - Minard-Colin, Véronique

AU - Chisholm, Julia C

PY - 2022/2

Y1 - 2022/2

KW - Child

KW - Humans

KW - Irinotecan

KW - Rhabdomyosarcoma

KW - Sarcoma

KW - Temozolomide

KW - Therapies, Investigational

KW - Vincristine

UR - https://www.mendeley.com/catalogue/310c081f-4029-33f7-94c9-83873eef6bbc/

U2 - 10.1200/JCO.21.02612

DO - 10.1200/JCO.21.02612

M3 - Article

C2 - 35130027

SN - 0732-183X

VL - 40

SP - 1030

EP - 1032

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 9

ER -